These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21209479)

  • 1. Impact of technology overlapping: a case study on colorectal cancer screening.
    Di Bidino R; Cicchetti A; Corio M; Polisena J; Oradei M; Marchetti M
    Technol Health Care; 2010; 18(4-5):303-15. PubMed ID: 21209479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening based on risk for colorectal cancer is the most cost-effective approach.
    Dan YY; Chuah BY; Koh DC; Yeoh KG
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):266-71.e1-6. PubMed ID: 22100624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of various strategies for colorectal cancer screening tests.
    Wohl P; Bednařík M; Wohl P; Cervenka M; Spičák J
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1157-64. PubMed ID: 21989120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and programmatic costs of implementing colorectal cancer screening: evaluation of five programs.
    Subramanian S; Tangka FK; Hoover S; Degroff A; Royalty J; Seeff LC
    Eval Program Plann; 2011 May; 34(2):147-53. PubMed ID: 21036399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of capsule endoscopy in screening for colorectal cancer.
    Hassan C; Zullo A; Winn S; Morini S
    Endoscopy; 2008 May; 40(5):414-21. PubMed ID: 18302080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stool occult blood testing: comparison.
    Wiwanitkit V
    Am J Gastroenterol; 2010 Dec; 105(12):2709. PubMed ID: 21131944
    [No Abstract]   [Full Text] [Related]  

  • 8. Colorectal cancer screening: physician attitudes and practices.
    Taylor ML; Anderson R
    WMJ; 2002; 101(5):39-43. PubMed ID: 12239980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer screening in an expanding panorama of screening programmes.
    Hoff G
    Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):521-7. PubMed ID: 20833354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Colorectal cancer screening].
    Castells A
    Gastroenterol Hepatol; 2011 Oct; 34 Suppl 2():60-6. PubMed ID: 22330158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer screening in Europe: compliance and the choice of test.
    Riemann JF
    Endoscopy; 2010 Jul; 42(7):576-7. PubMed ID: 20593335
    [No Abstract]   [Full Text] [Related]  

  • 12. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection of colorectal cancer with faecal occult blood test screening.
    Paimela H; Malila N; Palva T; Hakulinen T; Vertio H; Järvinen H
    Br J Surg; 2010 Oct; 97(10):1567-71. PubMed ID: 20603855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer (Br J Surg 2009; 96: 533-540).
    Nash GF
    Br J Surg; 2009 Aug; 96(8):956-7; author reply 957. PubMed ID: 19591144
    [No Abstract]   [Full Text] [Related]  

  • 15. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Introduction.
    Lansdorp-Vogelaar I; von Karsa L;
    Endoscopy; 2012 Sep; 44 Suppl 3():SE15-30. PubMed ID: 23012118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences in performance of fecal occult blood testing.
    Brenner H; Haug U; Hundt S
    Am J Gastroenterol; 2010 Nov; 105(11):2457-64. PubMed ID: 20700114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of colorectal cancer.
    Winawer SJ
    Surg Oncol Clin N Am; 2005 Oct; 14(4):699-722. PubMed ID: 16226687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of colorectal cancer screening strategies in Singapore: a dynamic decision analytic approach.
    Wong SS; Leong AP; Leong TY
    Stud Health Technol Inform; 2004; 107(Pt 1):104-10. PubMed ID: 15360784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a selective screening for colorectal carcinoma: the Taiwan Multicenter Cancer Screening (TAMCAS) project.
    Chen TH; Yen MF; Lai MS; Koong SL; Wang CY; Wong JM; Prevost TC; Duffy SW
    Cancer; 1999 Oct; 86(7):1116-28. PubMed ID: 10506694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of colorectal cancer screening with computed tomography colonography or fecal blood tests.
    Heresbach D; Chauvin P; Grolier J; Josselin JM
    Eur J Gastroenterol Hepatol; 2010 Nov; 22(11):1372-9. PubMed ID: 20802341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.